Barclays raised the firm’s price target on Nutanix (NTNX) to $94 from $87 and keeps an Overweight rating on the shares. The company had a solid fiscal Q2 while raising its full year guidance, the analyst tells investors in a research note. The firm says Nutanix’s share gain story remains intact. It remains constructive on the company’s deal activity for 2025 and beyond.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix Positioned for Growth: Strong Financials, Strategic Partnerships, and Raised Guidance Justify Buy Rating
- Nutanix Inc. Reports Strong Q2 2025 Financial Results
- Nutanix reports Q2 EPS 56c, consensus 47c
- Nutanix sees Q3 revenue $620M-$630M, consensus $595.12M
- Nutanix sees FY25 revenue $2.5B-$2.52B, consensus $2.46B